文献速递慢性肾脏病血液净化与透析

基于风险策略指导抢先等待名单登记及种族/族裔等待时间公平性

Strategies to Guide Preemptive Waitlisting and Equity in Waittime Accrual by Race/Ethnicity.
PubMed 文献 · Clin J Am Soc Nephrol · 2023-11-06

该研究利用电子健康记录数据,在1290名CKD 4-5期成人中比较两种确定等待名单资格的策略:eGFR≤20阈值 vs KFRE 2年风险25%阈值,模型计算可累积的抢先等待时间。结果发现使用KFRE阈值时,黑种人、西班牙裔和亚裔/太平洋岛民患者与非西班牙裔白种人患者之间的等待时间差异较eGFR阈值时缩小,且在亚裔/太平洋岛民中仍具统计学显著性。结论认为基于风险的策略与更大的种族公平性相关。

要点

  • 使用eGFR≤20阈值时,黑种人、西班牙裔和亚裔/太平洋岛民患者可累积的抢先等待时间较非西班牙裔白种人患者更短。
  • 使用KFRE 2年风险25%阈值时,上述种族/族裔间的等待时间差异缩小,但仅在亚裔/太平洋岛民中仍具统计学显著性。
  • KFRE阈值与eGFR阈值相比,在黑种人、西班牙裔和亚裔/太平洋岛民患者中均显示出更公平的等待时间(P值分别为0.02、0.002、0.002)。

核心结论

  • 使用基于风险的策略(KFRE 2年风险25%)确定抢先等待名单资格,与使用标准单一eGFR阈值相比,在等待时间累积方面与更大的种族公平性相关。

研究设计与样本

  • 利用电子健康记录数据的线性混合模型分析,纳入1290名CKD 4-5期成人,比较两种策略下按种族/族裔可累积的抢先等待时间差异。

主要发现

  • 使用CKD-EPI方程时,eGFR从20降至5 ml/min per 1.73 m²之间的抢先等待时间,黑种人患者较非西班牙裔白种人患者短6.8个月(95%CI -11.7至-1.9),西班牙裔短10.2个月(95%CI -15.3至-5.1),亚裔/太平洋岛民短10.3个月(95%CI -15.3至-5.4)。
  • 使用KFRE阈值时,黑种人患者较非西班牙裔白种人患者短2.5个月(95%CI -7.8至2.7),西班牙裔短4.8个月(95%CI -10.3至0.6),亚裔/太平洋岛民短5.4个月(95%CI -10.7至-0.1),但仅亚裔/太平洋岛民达到统计学显著性。
  • 比较KFRE与eGFR阈值,KFRE在黑种人(P=0.02)、西班牙裔(P=0.002)和亚裔/太平洋岛民(P=0.002)患者中均显示出更公平的等待时间。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Use of eGFR to determine preemptive waitlisting eligibility may contribute to racial/ethnic disparities in access to waitlisting, which can only occur when the eGFR falls to ≤20 ml/min per 1.73 m 2 . Use of an alternative risk-based strategy for waitlisting may reduce these inequities ( e.g. , a kidney failure risk equation [KFRE] estimated 2-year risk of kidney failure) rather than the standard eGFR threshold for determining waitlist eligibility. Our objective was to model the amount of preemptive waittime that could be accrued by race and ethnicity, applying two different strategies to determine waitlist eligibility. METHODS: Using electronic health record data, linear mixed models were used to compare racial/ethnic differences in preemptive waittime that could be accrued using two strategies: estimating the time between an eGFR ≤20 and 5 ml/min per 1.73 m 2 versus time between a 25% 2-year predicted risk of kidney failure (using the KFRE, which incorporates age, sex, albuminuria, and eGFR to provide kidney failure risk estimation) and eGFR of 5 ml/min per 1.73 m 2 . RESULTS: Among 1290 adults with CKD stages 4-5, using the Chronic Kidney Disease Epidemiology Collaboration equation yielded shorter preemptive waittime between an eGFR of 20 and 5 ml/min per 1.73 m 2 in Black (-6.8 months; 95% confidence interval [CI], -11.7 to -1.9), Hispanic (-10.2 months; -15.3 to -5.1), and Asian/Pacific Islander (-10.3 months; 95% CI, -15.3 to -5.4) patients compared with non-Hispanic White patients. Use of a KFRE threshold to determine waittime yielded smaller differences by race and ethnicity than observed when using a single eGFR threshold, with shorter time still noted for Black (-2.5 months; 95% CI, -7.8 to 2.7), Hispanic (-4.8 months; 95% CI, -10.3 to 0.6), and Asian/Pacific Islander (-5.4 months; -10.7 to -0.1) individuals compared with non-Hispanic White individuals, but findings only met statistical significance criteria in Asian/Pacific Islander individuals. When we compared potential waittime availability using a KFRE versus eGFR threshold, use of the KFRE yielded more equity in waittime for Black ( P = 0.02), Hispanic ( P = 0.002), and Asian/Pacific Islander ( P = 0.002) patients. CONCLUSIONS: Use of a risk-based strategy was associated with greater racial equity in waittime accrual compared with use of a standard single eGFR threshold to determine eligibility for preemptive waitlisting.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Ku E, Copeland T, Chen LX, et al. Strategies to Guide Preemptive Waitlisting and Equity in Waittime Accrual by Race/Ethnicity. Clin J Am Soc Nephrol. 2023. PMID: 37930674. doi:10.2215/CJN.0000000000000354

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。